Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 4, 2001, Pages 1225-1230

  Kanamoto, T ^a   Kashiwada, Y ^a   Kanbara, K ^a   Gotoh, K ^a   Yoshimori, M ^a   Goto, T ^a   Sano, K ^a   Nakashima, H ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 O (3',3' DIMETHYSUCCINYL) BETULINIC ACID; BETULIC ACID; TRITERPENOID; UNCLASSIFIED DRUG; VIRUS PROTEIN; YK FH312;

ANTIVIRAL ACTIVITY; ARTICLE; ASSAY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG ACTIVITY; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; PLANT LEAF; PRIORITY JOURNAL; SYNCYTIUM; VIRION; VIROGENESIS; VIRUS ASSEMBLY; VIRUS REPLICATION; WESTERN BLOTTING;

ANTI-HIV AGENTS; CELL FUSION; FORMAZANS; GIANT CELLS; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; TETRAZOLIUM SALTS; TIME FACTORS; TRITERPENES; TUMOR CELLS, CULTURED; VIRAL PROTEINS; VIRION;

EID: 0035087062     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.4.1225-1230.2001     Document Type: Article

References (16)

1. T134, a smallmolecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with a different structure
2. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
3. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
4. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
5. Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids
6. Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents
7. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene
8. Contrast-enhancement for the image of human immunodeficiency virus from ultrathin section by immuno electron microscopy
9. Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an in vitro competitive HIV-1 replication assay
10. Recent developments in HIV protease inhibitor therapy
11. FR901724, a novel anti-human immunodeficiency virus (HIV) peptide produced by Streptomyces, shows synergistic antiviral activities with HIV protease inhibitor and 2′,3′-dideoxynucleosides
12. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): A possible inhibitor of virus-cell fusion
13. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
14. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
15. Lecithinized superoxide dismutase: An inhibitor of human immunodeficiency virus replication
16. Human immunodeficiency virus (HIV)-induced cell fusion: Quantification and its application for the simple and rapid screening of anti-HIV substances in vitro